検索結果 - Valeria Santini

結果の絞り込み
  1. 1
    Treatment of low-risk myelodysplastic syndromes

    Treatment of low-risk myelodysplastic syndromes 著者: Valeria Santini

    出版事項 2016
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    How I treat MDS after hypomethylating agent failure

    How I treat MDS after hypomethylating agent failure 著者: Valeria Santini

    出版事項 2018
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Iron metabolism and iron deficiency anemia in women

    Iron metabolism and iron deficiency anemia in women 著者: Maria Domenica Cappellini, Valeria Santini, Cecilia Braxs, Aryeh Shander

    出版事項 2022
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 著者: Pierre Fenaux, Dagmar Haase, Guillermo Sanz, Valeria Santini, Christian Buske

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Autonomous Proliferation of Leukemic Cells in Vitro as a Determinant of Prognosis in Adult Acute Myeloid Leukemia

    Autonomous Proliferation of Leukemic Cells in Vitro as a Determinant of Prognosis in Adult Acute Myeloid Leukemia 著者: Bob Lowenberg, Wim van Putten, Ivo P. Touw, Ruud Delwel, Valeria Santini

    出版事項 1993
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆

    Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆ 著者: Pierre Fenaux, Dagmar Haase, Valeria Santini, Guillermo Sanz, Uwe Platzbecker, Ulrich Mey

    出版事項 2020
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy

    Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy 著者: Anna Rita Bizzarri, Valeria Santini, Bucciantini, D Agostino, Tohru Yamada, R. Mark Beattie, Salvatore Cannistraro

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Why methylation is not a marker predictive of response to hypomethylating agents

    Why methylation is not a marker predictive of response to hypomethylating agents 著者: Maria Teresa Voso, Valeria Santini, Emiliano Fabiani, Luana Fianchi, Marianna Criscuolo, Giulia Falconi, Francesco Guidi, Stefan Hohaus, Giuseppe Leone

    出版事項 2014
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  9. 9
    STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2

    STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2 著者: Amer M. Zeidan, Aristoteles Giagounidis, Mikkael A. Sekeres, Zhijian Xiao, Guillermo Sanz, Marlies Van Hoef, Fei Ma, Sabine Hertle, Valeria Santini

    出版事項 2023
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Azacitidine for the treatment of lower risk myelodysplastic syndromes

    Azacitidine for the treatment of lower risk myelodysplastic syndromes 著者: Pellegrino Musto, Luca Maurillo, Alessandra Spagnoli, Antonella Gozzini, Flavia Rivellini, Monia Lunghi, Oreste Villani, Maria Antonietta Aloe Spiriti, Adriano Venditti, Valeria Santini

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia

    Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia 著者: Elisabetta Antonioli, Paola Guglielmelli, G Poli, Costanza Bogani, Alessandro Pancrazzi, Giovanni Longo, Vanessa Ponziani, Lorenzo Tozzi, Lisa Pieri, Valeria Santini, Alberto Bosi, Alessandro M. Vannucchi

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

    Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes 著者: Valeria Santini, Domenico Girelli, Alessandro Sanna, Nicola Martinelli, Lorena Duca, Natascia Campostrini, Agostino Cortelezzi, Michela Corbella, Alberto Bosi, Gianluigi Reda, Oliviero Olivieri, Maria Domenica Cappellini

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes

    Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes 著者: Lewis R. Silverman, Pierre Fenaux, Ghulam J. Mufti, Valeria Santini, Eva Hellström‐Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*

    Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine* 著者: Valeria Santini, Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg, Lewis R. Silverman, Alan F. List, Steven D. Gore, John F. Seymour, Jay T. Backstrom, Charles L. Beach

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

    A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care... 著者: Steven D. Gore, Pierre Fenaux, Valeria Santini, John M. Bennett, L.R. Silverman, John F. Seymour, Eva Hellström‐Lindberg, Arlene S. Swern, C.L. Beach, Alan F. List

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes

    Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes 著者: John F. Seymour, Pierre Fenaux, Lewis R. Silverman, Ghulam J. Mufti, Eva Hellström‐Lindberg, Valeria Santini, Alan F. List, Steven D. Gore, Jay T. Backstrom, David R. McKenzie, C.L. Beach

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine

    Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine 著者: Ana Valencia, Erico Masala, Alessia Rossi, Alessandro Di Martino, Alessandro Sanna, Francesca Buchi, Federico Canzian, Daniela Cilloni, Valentina Gaidano, Maria Teresa Voso, Olivier Kosmider, Michaëla Fontenay, Antonella Gozzini, Alberto Bosi, Valeria Santini

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

    Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? 著者: Olivier Kosmider, Marie Passet, Valeria Santini, Uwe Platzbecker, Valérie Andrieu‐Ponel, Gina Zini, Odile Beyne‐Rauzy, A. Guerci, Erico Masala, Enrico Balleari, Ekaterina Bulycheva, François Dreyfus, Pierre Fenaux, Michaëla Fontenay, Sophie Park

    出版事項 2016
    全文の入手
    Carta
    お気に入りに追加
    保存先:
  19. 19
    Genome-wide methylome modeling via generative AI incorporating long- and short-range interactions

    Genome-wide methylome modeling via generative AI incorporating long- and short-range interactions 著者: Fengyao Yan, Aristeidis G. Telonis, Qin Yang, Limin Jiang, Francine E. Garrett-Bakelman, Mikkael A. Sekeres, Valeria Santini, Michele Ceccarelli, Neha Goel, Liliana Garcia-Martinez, Lluís Morey, María E. Figueroa, Yan Guo

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

    Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines 著者: Matti Aapro, Yves Béguin, Carsten Bokemeyer, Mario Dicato, Pere Gascón, John A. Glaspy, Axel Hofmann, Hartmut Link, T. Littlewood, Heinz Ludwig, Anders Österborg, P. Pronzato, Valeria Santini, D. Schrijvers, R. Stauder, Kim Jordan, Jørn Herrstedt

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: